112 related articles for article (PubMed ID: 8543759)
1. Effect of topical doxepin cream on skin testing.
Karaz SS; Moeckli JK; Davis W; Craig TJ
J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 1):997-8. PubMed ID: 8543759
[No Abstract] [Full Text] [Related]
2. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
3. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.
Groene D; Martus P; Heyer G
Exp Dermatol; 2001 Apr; 10(2):110-7. PubMed ID: 11260249
[TBL] [Abstract][Full Text] [Related]
4. Doxepin incorporated into a dermatologic cream: an assessment of both doxepin antipruritic action and doxepin action as an inhibitor of papules, in allergen and histamine-caused pruritus.
Greiding L; Moreno P
Allergol Immunopathol (Madr); 1999; 27(5):265-70. PubMed ID: 10568877
[TBL] [Abstract][Full Text] [Related]
5. Doxepin toxicity in a child following topical administration.
Zell-Kanter M; Toerne TS; Spiegel K; Negrusz A
Ann Pharmacother; 2000 Mar; 34(3):328-9. PubMed ID: 10917379
[TBL] [Abstract][Full Text] [Related]
6. Systemic adverse effects from topical doxepin cream.
Jones ME; Skaufle ML
Ann Pharmacother; 2001 Apr; 35(4):505-6. PubMed ID: 11302417
[No Abstract] [Full Text] [Related]
7. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience.
Bonnel RA; La Grenade L; Karwoski CB; Beitz JG
J Am Acad Dermatol; 2003 Feb; 48(2):294-6. PubMed ID: 12582408
[TBL] [Abstract][Full Text] [Related]
8. Allergic contact dermatitis from doxepin cream.
Rapaport MJ
Arch Dermatol; 1996 Dec; 132(12):1516-8. PubMed ID: 8961889
[No Abstract] [Full Text] [Related]
9. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience.
Taylor JS; Praditsuwan P; Handel D; Kuffner G
Arch Dermatol; 1996 May; 132(5):515-8. PubMed ID: 8624147
[TBL] [Abstract][Full Text] [Related]
10. Use of topical doxepin for the treatment of burn scar pruritus in adults: An inaccessible therapeutic alternative?
Queruel P; Bartholomei MN; Chauvineau-Mortelette V; Cabaret E; Bartoli JL; Naville L; Laveix I; Arnaudo L
Burns; 2020 Feb; 46(1):246-247. PubMed ID: 31859092
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis.
Drake LA; Cohen L; Gillies R; Flood JG; Riordan AT; Phillips SB; Stiller MJ
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):209-14. PubMed ID: 10426891
[TBL] [Abstract][Full Text] [Related]
12. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
13. Topical Antihistamines and Mast Cell Stabilizers for Treating Allergic Conjunctivitis.
Mounsey AL; Gray RE
Am Fam Physician; 2016 Jun; 93(11):915-6. PubMed ID: 27281835
[No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis due to doxepin cream in a patient with dystrophic epidermolysis bullosa.
Horn HM; Tidman MJ; Aldridge RD
Contact Dermatitis; 2001 Aug; 45(2):115. PubMed ID: 11553128
[No Abstract] [Full Text] [Related]
15. Toxic reaction from topically applied doxepin in a child with eczema.
Vo MY; Williamsen AR; Wasserman GS
Arch Dermatol; 1995 Dec; 131(12):1467-8. PubMed ID: 7492150
[No Abstract] [Full Text] [Related]
16. The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis.
Berberian BJ; Breneman DL; Drake LA; Gratton D; Raimir SS; Phillips S; Sulica VI; Bernstein JE
Int J Dermatol; 1999 Feb; 38(2):145-8. PubMed ID: 10192169
[No Abstract] [Full Text] [Related]
17. Sudden onset of generalized scaly eruptions.
Zawar V
J Fam Pract; 2012 Sep; 61(9):557-9. PubMed ID: 23000665
[No Abstract] [Full Text] [Related]
18. Dose escalation of doxepin for intractable pruritus.
Beck KM; Yang EJ; Koo J
J Am Acad Dermatol; 2018 Sep; 79(3):e37. PubMed ID: 30119870
[No Abstract] [Full Text] [Related]
19. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: development, characterization and in vivo evaluation.
Sandig AG; Campmany AC; Campos FF; Villena MJ; Naveros BC
Colloids Surf B Biointerfaces; 2013 Mar; 103():558-65. PubMed ID: 23261580
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic modulation of the whealing response to histamine in human skin: identification of doxepin as a potent in vivo inhibitor.
Sullivan TJ
J Allergy Clin Immunol; 1982 Mar; 69(3):260-7. PubMed ID: 6120966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
